Monday, January 10, 2005

Nanoparticles clobber cancer with sneak attack

First Nanotechnology Drug Approved for Breast Cancer (WNEP)

    If you or a loved one suffer from breast cancer, listen up. The government has just approved the first ever chemotherapy drug that uses nanotechnology to fight metastatic breast cancer. It's called Abraxane. It replaces toxic chemical treatment, with tiny packages of the drug paclitaxel and the natural protein albumin.

    Researchers say the cancer cells believe they're taking in nutrients to help them grow, when they're really taking in the cancer fighting drug. Annice O'Brien took part in the study, "It made me once again feel like i'm going to beat this."

    Dr. William Gradishar, Northwestern University, "Abraxane is a new effective chemotherarpy drug for the treatment of metastatic breast cancer that can be administered over a very short period of time, and is well tolerated by patients." More here

Related News
Nanoparticle Breast Cancer Treatment Approved (Better Humans)
(USON) Plays Important Ongoing Role In Newly Approved ABRAXANE (US Oncology Inc.)
Lynn Sage Comprehensive Breast Center plays role in newly approved breast cancer drug, ABRAXANE (EurekAlert)

NanoBot Backgrounder
Learning a living with Luna
Poplar protein proves perfect for pushing prescriptions
NanoDoctors hold online office hours

No comments: